High GPX1 expression promotes esophageal squamous cell carcinoma invasion, migration, proliferation and cisplatin-resistance but can be reduced by vitamin D

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 9, 2014, Pages 2530-2540

  Gan, Xiangfeng ^a   Chen, Baishen ^a   Shen, Zhuojian ^a   Liu, Yeqing ^a   Li, Haifeng ^a   Xie, Xuan ^a   Xu, Xia ^a   Li, Haigang ^a   Huang, Zhiquan ^a   Chen, Ju ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Glutathione peroxidase 1; Invasion; Matrix metalloproteinase 2; Migration; NF B; Urokinase type plasminogen activator; Vitamin D

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CHOLECYSTOKININ OCTAPEPTIDE; CISPLATIN; GELATINASE A; GLUTATHIONE PEROXIDASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UROKINASE; VITAMIN D;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; METASTASIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; TUMOR GROWTH; TUMOR INVASION; WESTERN BLOTTING;

EID: 84907856083     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Napier KJ, Scheerer M and Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 2014; 6: 112-120.
2. Quatromoni JG, Predina JD, Bhojnagarwala P, Judy RP, Jiang J, De Jesus EM, Kapoor V, Cheng G, Okusanya OT, Eruslanov E and Singhal S. Adenoviral-based immunotherapy provides local disease control in an orthotopic murine model of esophageal cancer. J Immunother 2014; 37: 283-292.
3. Baba Y, Watanabe M, Yoshida N and Baba H. Neoadjuvant treatment for esophageal squamous cell carcinoma. World J Gastrointest Oncol 2014; 6: 121-128.
4. Grimm JC, Valero VR and Molena D. Surgical indications and optimization of patients for resectable esophageal malignancies. J Thorac Dis 2014; 6: 249-257.
5. Courrech SE, van Coevorden F, Cats A, Aleman BM, van Velthuysen ML, Boot H, Peeters MJ and van Sandick JW. Outcome of low-volume surgery for esophageal cancer in a high-volume referral center. Ann Surg Oncol 2009; 16: 3219-3226.
6. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci 2000; 57: 1825-1835.
7. Cao M, Mu X, Jiang C, Yang G, Chen H and Xue W. Single-nucleotide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: a systematic review and meta-analysis. Tumour Biol 2014; 35: 759-764.
8. Yang J, Lam EW, Hammad HM, Oberley TD and Oberley LW. Antioxidant enzyme levels in oral squamous cell carcinoma and normal human oral epithelium. J Oral Pathol Med 2002; 31: 71-77.
9. Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 2006; 10: 175-176.
10. Fu TY, Hou YY, Chu ST, Liu CF, Huang CH, Chen HC, Hsiao M, Lu PJ, Wang JS and Ger LP. Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas. Head Neck 2011; 33: 1606-1615.
11. Vibet S, Goupille C, Bougnoux P, Steghens JP, Gore J and Maheo K. Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response. Free Radic Biol Med 2008; 44: 1483-1491.
12. Ho JC, Chan-Yeung M, Ho SP, Mak JC, Ip MS, Ooi GC, Wong MP, Tsang KW and Lam WK. Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma. Eur Respir J 2007; 29: 273-278.
13. Gong G, Meplan C, Gautrey H, Hall J and Hesketh JE. Differential effects of selenium and knock-down of glutathione peroxidases on TNFalpha and flagellin inflammatory responses in gut epithelial cells. Genes Nutr 2012; 7: 167-178.
14. Li Q, Sanlioglu S, Li S, Ritchie T, Oberley L and Engelhardt JF. GPx-1 gene delivery modulates NFkappaB activation following diverse environmental injuries through a specific subunit of the IKK complex. Antioxid Redox Signal 2001; 3: 415-432.
15. de Haan JB, Cristiano F, Iannello RC and Kola I. Cu/Zn-superoxide dismutase and glutathione peroxidase during aging. Biochem Mol Biol Int 1995; 35: 1281-1297.
16. Dibra D, Mishra L and Li S. Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: An underappreciated symbiotic relationship. Biochim Biophys Acta 2014; 1846: 152-160.
17. Thota C, Laknaur A, Farmer T, Ladson G, Al-Hendy A and Ismail N. Vitamin D regulates contractile profile in human uterine myometrial cells via NF-kappaB pathway. Am J Obstet Gynecol 2014; 210: 341-347.
18. Rosli SN, Shintani T, Hayashido Y, Toratani S, Usui E and Okamoto T. 1alpha,25OH2D3 down-regulates HBp17/FGFBP-1 expression via NF-kappaB pathway. J Steroid Biochem Mol Biol 2013; 136: 98-101.
19. Janjetovic Z, Brozyna AA, Tuckey RC, Kim TK, Nguyen MN, Jozwicki W, Pfeffer SR, Pfeffer LM and Slominski AT. High basal NF-kappaB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives. Br J Cancer 2011; 105: 1874-1884.
20. Tse AK, Zhu GY, Wan CK, Shen XL, Yu ZL and Fong WF. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells. Mol Immunol 2010; 47: 1728-1738.
21. Bao BY, Yao J and Lee YF. 1alpha,25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis 2006; 27: 1883-1893.
22. Ghashghaeinia M, Toulany M, Saki M, Bobbala D, Fehrenbacher B, Rupec R, Rodemann HP, Ghoreschi K, Rocken M, Schaller M, Lang F and Wieder T. The NFkB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes. Cell Physiol Biochem 2011; 27: 45-54.
23. Dye DE, Medic S, Ziman M and Coombe DR. Melanoma Biomolecules: Independently Identified but Functionally Intertwined. Front Oncol 2013; 3: 252.
24. Qian Q, Wang Q, Zhan P, Peng L, Wei SZ, Shi Y and Song Y. The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis. Cancer Invest 2010; 28: 661-669.
25. Simone TM, Higgins CE, Czekay RP, Law BK, Higgins SP, Archambeault J, Kutz SM and Higgins PJ. SERPINE1: A Molecular Switch in the Proliferation-Migration Dichotomy in Wound-”Activated” Keratinocytes. Adv Wound Care (New Rochelle) 2014; 3: 281-290.
26. Riabov V, Gudima A, Wang N, Mickley A, Orekhov A and Kzhyshkowska J. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol 2014; 5: 75.
27. Takata Y, Kristal AR, Santella RM, King IB, Duggan DJ, Lampe JW, Rayman MP, Blount PL, Reid BJ, Vaughan TL and Peters U. Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett’s esophagus: results from biomarkers and genetic variants. PLoS One 2012; 7: e38612.
28. Peng DF, Razvi M, Chen H, Washington K, Roessner A, Schneider-Stock R and El-Rifai W. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett’s adenocarcinoma. Gut 2009; 58: 5-15.
29. Goseki N, Koike M and Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 1992; 69: 1088-1093.
30. Huang C, Ding G, Gu C, Zhou J, Kuang M, Ji Y, He Y, Kondo T and Fan J. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1alpha to promote hepatocellular carcinoma invasiveness. Clin Cancer Res 2012; 18: 3042-3053.
31. Mahmoud AM, Yang W and Bosland MC. Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol 2014; 140: 116-132.
32. Peng WH, Tien YC, Huang CY, Huang TH, Liao JC, Kuo CL and Lin YC. Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1. J Ethnopharmacol 2010; 127: 606-613.
33. Piantoni P, Wang P, Drackley JK, Hurley WL and Loor JJ. Expression of metabolic, tissue remodeling, oxidative stress, and inflammatory pathways in mammary tissue during involution in lactating dairy cows. Bioinform Biol Insights 2010; 4: 85-97.
34. Sul OJ, Kim JC, Kyung TW, Kim HJ, Kim YY, Kim SH, Kim JS and Choi HS. Gold nanoparticles inhibited the receptor activator of nuclear factor-kappab ligand (RANKL)-induced osteoclast formation by acting as an antioxidant. Biosci Biotechnol Biochem 2010; 74: 2209-2213.
35. Taylor JM, Crack PJ, Gould JA, Ali U, Hertzog PJ and Iannello RC. Akt phosphorylation and NFkappaB activation are counterregulated under conditions of oxidative stress. Exp Cell Res 2004; 300: 463-475.
36. Wang H, Khor TO, Yang Q, Huang Y, Wu TY, Saw CL, Lin W, Androulakis IP and Kong AN. Pharmacokinetics and pharmacodynamics of phase II drug metabolizing/antioxidant enzymes gene response by anticancer agent sulforaphane in rat lymphocytes. Mol Pharm 2012; 9: 2819-2827.
37. Gilmore TD. The Rel/NF-kappaB signal transduction pathway: introduction. Oncogene 1999; 18: 6842-6844.
38. Zhang W, Ling D, Tan J, Zhang J and Li L. Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance. Oncol Rep 2013; 29: 637-645.